allosct outcomes in patients who achieve cr with car-t versus chemotherapy in t-all/lbl
Published 5 months ago • 62 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:09
the role of allosct in lbcl in the era of car-t
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
1:33
patient selection for car-t in all
-
2:16
autosct vs car-t for patients with relapsed lbcl in pr: the role of total metabolic tumor volume
-
4:56
aplio a-series whc canon medical systems
-
4:53
acute myeloid leukemia
-
5:08
cellectis allogeneic car-t cells
-
0:52
challenges in treating infant all patients with car-t
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
4:21
mrd as a monitoring technique of allosct and car-t in aml/all
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
5:01
challenges of car t-cell treatment in pediatric all
-
3:33
determining the optimal sequencing of bispecifics and car-t cells in patients with myeloma
-
3:56
considerations and challenges of integrating car-t and transplantation in b-all
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
3:08
current car-t treatments for t-all and next steps
-
0:51
car-t as a frontline standard of care in all?
-
2:20
car-t assessment in the ambulatory care setting
-
0:51
developing universal car-t therapies for t-all
-
2:12
expanding the reach of car-t
-
1:46
optimizing conditioning regimens in patients with aml undergoing allosct